NDC 0378-9671-64 - Ipratropium Bromide and Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9671
- Requested NDC
- 0378-9671-64
- Package NDCs from labels
- 0378-9671-31, 0378-9671-93, 0378-9671-64, 0378-9671-30, 0378-9671-60
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2018-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2018-12-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9671-30 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 CARTON | SOLUTION | 1 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 POUCH | SOLUTION | 1 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 2 in 1 CARTON | SOLUTION | 2 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-93 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 CARTON | SOLUTION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9671-30 | ML - Milliliter | 0378-9671 | fecf8d7a-ca63-4086-a192-cfe09593da7f | 1 | 2016-03-04 |
| 0378-9671-31 | ML - Milliliter | 0378-9671 | 441e8202-3014-467f-839f-1cb56dd1ff5a | 1 | 2015-05-05 |
| 0378-9671-58 | ML - Milliliter | 0378-9671 | e0ed7cbb-725f-41b4-98a8-8e4fbac96aa5 | 1 | 2013-10-17 |
| 0378-9671-60 | ML - Milliliter | 0378-9671 | ac7fec3f-8285-492f-b246-26b74402bbb7 | 1 | 2016-04-04 |
| 0378-9671-91 | ML - Milliliter | 0378-9671 | 32a69a83-77f5-460b-ac59-cdb791096167 | 1 | 2014-04-03 |
| 0378-9671-93 | ML - Milliliter | 0378-9671 | f9a81245-211d-421f-9a2b-9b034708627c | 1 | 2013-07-02 |
| 0378-9671-98 | ML - Milliliter | 0378-9671 | d5fa01b8-04ef-4d82-bc9d-1bc4f51852f7 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albuterol Sulfate | ACTIVE INGREDIENT | 021SEF3731 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium Bromide | ACTIVE INGREDIENT | J697UZ2A9J | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Albuterol | ACTIVE MOIETY | QF8SVZ843E | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium | ACTIVE MOIETY | GR88G0I6UL | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 1d6be2b8-c670-b783-e063-6294a90ae503 | 2024-07-31 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Aurobindo Pharma Limited | 78e6bee2-7113-46cf-8c97-dc61b0f7b94f | 2024-07-31 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | b0f73459-baeb-42a7-be48-2c3647d9b205 | 2024-07-30 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | b478d9e9-9704-6af2-e053-2995a90aafd4 | 2024-07-17 | Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 7043bc12-8a58-8ff8-e053-2a91aa0ab627 | 2024-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 54d90668-5237-4330-e054-00144ff88e88 | 2024-07-15 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 8c278b6f-d32b-b750-e053-2995a90ad7e9 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 021SEF3731 |
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | A-S Medication Solutions | e452afc2-dc33-4be7-949e-143b2e5f530c | 2024-06-10 | Warnings, Adverse reactions | ANDA202496 1437702 J697UZ2A9J 021SEF3731 |
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | American Health Packaging | c04c6ec8-1401-424d-8126-63080e36c4b9 | 2024-06-03 | Warnings, Adverse reactions | ANDA202496 1437702 J697UZ2A9J 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | American Health Packaging | 8927f392-4c88-4ac1-a934-c444ecf6b2c8 | 2024-06-03 | Warnings, Adverse reactions | J697UZ2A9J |
| VENTOLIN HFA | ALBUTEROL SULFATE | A-S Medication Solutions | aa6d5c00-46a5-4f93-95e4-09319abfe71e | 2024-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | A-S Medication Solutions | 19867b61-77a2-46f1-97c7-7fadfec5882b | 2024-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | A-S Medication Solutions | aff836e4-34f2-4ab9-bbf8-0c41ac848cb0 | 2024-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Prasco Laboratories | b25d9d6b-eb4c-452e-89ef-10e611deebd6 | 2024-04-30 | Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | GlaxoSmithKline LLC | d92c5d6b-ff10-4087-36a2-1cfc464cb967 | 2024-04-26 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 767a1504-1e04-1e06-e053-2a91aa0aa4b6 | 2024-02-22 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC. | 7f261a9b-65d9-408a-8609-c1b3809b8b4b | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 4e48ccbe-3ec0-4bf2-be28-83eb9baa63d6 | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 922bf33b-4d55-4c35-9f68-72efbb17c14f | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | A-S Medication Solutions | 7ad17b39-d2de-4108-abbf-cedd650c8edd | 2024-02-18 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.